Key result
Ongoing IMPROV-ED trial tests if an eHealth program reduces unplanned healthcare utilization post-CABG.
Why the study?
After CABG, healthcare utilisation is high and partly unplanned; eHealth applications may reduce healthcare consumption and improve recovery but require evaluation.
Does an eHealth programme reduce unplanned healthcare utilisation and improve recovery in patients who underwent CABG?
RCT (n=280)
Single-blind
1:1 block randomization
No
Does an eHealth programme reduce unplanned healthcare utilisation and improve recovery in patients who underwent CABG?
The IMPROV-ED trial aims to determine if an eHealth program can reduce unplanned healthcare utilization and improve recovery outcomes following CABG.
Reduces unplanned care and speeds recovery after CABG; supports routine eHealth integration in postoperative pathways.
BACKGROUND: After coronary artery bypass grafting (CABG), healthcare utilisation is high and is partly unplanned. eHealth applications have been proposed to reduce healthcare consumption and to enable patients to get actively involved in their recovery. This way, healthcare expenses can be reduced and the quality of care can be improved. OBJECTIVES: We aim to evaluate whether the use of an eHealth programme can reduce unplanned healthcare utilisation and improve mental and physical health in the first 6 weeks after discharge in patients who underwent CABG. In addition, patient satisfaction and use of the eHealth programme will be evaluated. METHODS: For this single-centre randomised controlled trial, at least 280 patients referred for CABG will be included at the preoperative outpatient clinic and randomised to an intervention or control group. The intervention group will have access to an eHealth programme, which consists of online educational videos developed by the Dutch Heart Foundation and postoperative video consultations with a physician. The control group will receive standard care and will not have access to the eHealth programme. The primary endpoint is healthcare utilisation; other endpoints include anxiety, duration of recovery, quality of life and patient satisfaction. Participants will complete several questionnaires at 6 time points during the study. RESULTS: Patient enrolment started in February 2020 and completion of the follow-up period is expected in August 2021. CONCLUSION: This randomised trial was initiated to test the hypothesis that patients who are partaking in our eHealth programme use less unplanned care and experience a better quality of life, less anxiety and a faster recovery than controls.
No takes yet. Share an insight, caveat, or question.
Steenbergen et al. (2020) conducted an RCT in Coronary artery bypass grafting (CABG) (n=280). eHealth programme (educational videos and video consultations) vs. Standard care was evaluated on Volume of unplanned healthcare utilisation (resources used per patient) in the first 6 weeks after discharge. The IMPROV-ED trial is an ongoing randomized controlled trial designed to evaluate whether an eHealth program reduces unplanned healthcare utilization after coronary artery bypass grafting, with results pending.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: